Admin Portal
Data Dashboard
INHALEarning
Ask the Pharmacist
Contact Us

Short-Acting Beta Agonists Dispensed

Description:

Our short-acting beta agonist use (dispensed) measure uses claims data to determine the percentage of patients in our population (Adult Asthma, Pediatric Asthma, and COPD) who were identified as having asthma or COPD with 0-2, 3-5, or 6 or more SABA inhaler medication fills in the measurement year.  A lower percentage of patients with three or more fills indicated better performance.

Population Specifics:

  • Asthma patients, regardless of severity, aged 5 years and older.
  • COPD patients aged 40 years and older.

Numerator/Denominator

  • Denominator: Eligible patients, as defined above, with at least one prescription claim in the measurement year.
  • Numerator: Eligible patient included in the denominator for whom a SABA inhaler medication is dispensed 0-2, 3-5, or 6+ time in the measurement year.

Guideline Links:

Subscribe to Our Newsletter

INHALE prepares regular PO and Clinical level newsletters that contain:

  • coordinating center updates
  • upcoming important events
  • tips and tricks for utilizing our website and portals
  • relevant articles and resources
  • and the latest asthma and COPD research
Twitter Instagram Youtube Linkedin


Arbor Lakes Building 3, Floor 3
4251 Plymouth Rd.
Ann Arbor, MI 48105

Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs. 

Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.